📰 Alvr News
Page 3 - Alvr News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alvr. Real-time updates on events, politics, business and more.
July 6, 2023
AlloVir, Inc. (NASDAQ:ALVR – Free Report) CEO Diana Brainard sold 5,275 shares of the company’s stock in a transaction on Wednesday, July 5th. The stock was sold at an average price of $3.05, for a total value of $16,088.75. Following the sale, the chief executive officer now owns 915,641 shares of the company’s stock, valued […]
July 1, 2023
AlloVir, Inc. (NASDAQ:ALVR – Free Report) major shareholder Gilead Sciences, Inc. acquired 2,930,870 shares of the stock in a transaction dated Tuesday, June 27th. The stock was acquired at an average cost of $3.75 per share, with a total value of $10,990,762.50. Following the completion of the transaction, the insider now owns 16,635,286 shares in […]
June 29, 2023
AlloVir (NASDAQ:ALVR – Free Report) and Vitro Diagnostics (OTCMKTS:VODG – Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Earnings and Valuation This table compares AlloVir and Vitro Diagnostics’ top-line […]
June 22, 2023
By Chris Wack AlloVir shares were down 28% to $3.55 after the company said it priced an underwritten public offering of 20 million shares at $3.75 a share....
June 16, 2023
AlloVir, Inc. (NASDAQ:ALVR – Get Rating) CAO Brett R. Hagen sold 5,045 shares of AlloVir stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $5.64, for a total transaction of $28,453.80. Following the sale, the chief accounting officer now directly owns 129,512 shares in the […]
June 9, 2023
AlloVir, Inc. (NASDAQ:ALVR – Get Rating) was up 22.4% during mid-day trading on Tuesday . The stock traded as high as $5.99 and last traded at $5.46. Approximately 449,994 shares traded hands during mid-day trading, an increase of 79% from the average daily volume of 250,811 shares. The stock had previously closed at $4.46. Wall […]
June 8, 2023
AlloVir, Inc. (NASDAQ:ALVR – Get Rating)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $5.82, but opened at $5.70. AlloVir shares last traded at $5.74, with a volume of 28,602 shares traded. Wall Street Analyst Weigh In Separately, SVB Securities upped their target price on shares […]
April 30, 2023
AlloVir (NASDAQ:ALVR – Get Rating) had its price objective upped by SVB Securities from $16.00 to $19.00 in a report issued on Wednesday morning, The Fly reports. ALVR has been the subject of a number of other reports. Morgan Stanley decreased their target price on AlloVir from $27.00 to $20.00 and set an overweight rating […]
April 26, 2023
AlloVir (NASDAQ:ALVR – Get Rating) had its price objective boosted by research analysts at SVB Securities from $16.00 to $19.00 in a report issued on Wednesday, The Fly reports. SVB Securities’ target price would suggest a potential upside of 420.55% from the company’s current price. Other equities analysts have also recently issued reports about the […]
April 22, 2023
AlloVir, Inc. (NASDAQ:ALVR – Get Rating) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 6,460,000 shares, an increase of 11.6% from the March 15th total of 5,790,000 shares. Based on an average daily trading volume, of 277,500 shares, the short-interest ratio is […]